AB
Adaptive Biotechnologies Corp
🇺🇸XNAS.ADPTUnited StatesHealthcare
$27.31USDup +0.65 (+2.44%)OpenDelayed3:26 PM
Price$27.31+0.65 (+2.44%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00650F1093
- CUSIP
- 00650F109
Company
- Employees
- 624
- Headquarters
- Seattle, United States
- CEO
- Mr. Chad M. Robins M.B.A.
Market
- Shares outstanding
- 159.6M
- Market cap
- $4.36B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $4.25B
- EPS LTM
- -$0.40
- P/E LTM
- -51.67
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $308.08M+50.13%up year on year
- Net income
- -$63.85M+47.33%up year on year
- Gross margin
- 75.44%+14.23%up year on year
- Free cash flow
- -$24.03M+70.98%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.